Iron Deficiency in COPD Associates with Increased Pulmonary Artery Pressure Estimated by Echocardiography

Heart Lung and Circulation

Volumn 26, Issue 1, 2017, Pages 101-104

  Plesner, Louis L ^a   Schoos, Mikkel M ^b   Dalsgaard, Morten ^a   Goetze, Jens P ^c   Kjøller, Erik ^a   Vestbo, Jørgen ^d   Iversen, Kasper ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b ZEALAND UNIVERSITY HOSPITAL   (Denmark)

^c Rigshospitalet   (Denmark)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Chronic obstructive pulmonary disease; Echocardiography; Ferritin; Iron deficiency; Pulmonary hypertension; Systolic pulmonary artery pressure

Indexed keywords

C REACTIVE PROTEIN; FERRITIN; IRON;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DIFFUSION CAPACITY OF CARBON MONOXIDE; FEMALE; FORCED EXPIRATORY VOLUME; HEMODYNAMIC PARAMETERS; HUMAN; IRON DEFICIENCY; LUNG ARTERY PRESSURE; LUNG DIFFUSION CAPACITY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTPATIENT; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SMOKING; TRANSTHORACIC ECHOCARDIOGRAPHY; TRICUSPID REGURGITATION MAXIMUM VELOCITY; BLOOD PRESSURE; DEFICIENCY; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; MIDDLE AGED; PATHOPHYSIOLOGY; PULMONARY ARTERY;

AGED; BLOOD PRESSURE; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION, PULMONARY; IRON; MALE; MIDDLE AGED; PULMONARY ARTERY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84978380782     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2016.04.020     Document Type: Article

References (15)

1. [1] Chaouat, A., Naeije, R., Weitzenblum, E., Pulmonary hypertension in COPD. Eur Respir J 32 (2008), 1371–1385.
2. [2] Smith, T.G., Talbot, N.P., Privat, C., Rivera-Ch, M., Nickol, A.H., Ratcliffe, P.J., et al. Effects of iron supplementation and depletion on hypoxic pulmonary hypertension: two randomized controlled trials. JAMA 302 (2009), 1444–1450.
3. [3] Smith, T.G., Balanos, G.M., Croft, Q.P.P., Talbot, N.P., Dorrington, K.L., Ratcliffe, P.J., et al. The increase in pulmonary arterial pressure caused by hypoxia depends on iron status. J Physiol 586:Pt 24 (2008), 5999–6005.
4. [4] Balanos, G.M., Dorrington, K.L., Robbins, P.A., Desferrioxamine elevates pulmonary vascular resistance in humans: potential for involvement of HIF-1. J Appl Physiol 92 (2002), 2501–2507.
5. [5] Sutendra, G., Bonnet, S., The iron paradigm of pulmonary arterial hypertension: Popeye knows best. Circ Res 116 (2015), 1636–1638.
6. [6] Wong, C-M., Preston, I.R., Hill, N.S., Suzuki, Y.J., Iron chelation inhibits the development of pulmonary vascular remodeling. Free Radic Biol Med 53 (2012), 1738–1747.
7. [7] Cotroneo, E., Ashek, A., Wang, L., Wharton, J., Dubois, O., Bozorgi, S., et al. Iron homeostasis and pulmonary hypertension: iron deficiency leads to pulmonary vascular remodeling in the rat. Circ Res 116 (2015), 1680–1690.
8. [8] Schoos, M.M., Dalsgaard, M., Kjærgaard, J., Moesby, D., Jensen, S.G., Steffensen, et al. Echocardiographic predictors of exercise capacity and mortality in chronic obstructive pulmonary disease. BMC Cardiovasc Disord, 13, 2013, 84.
9. [9] Galiè, N., Humbert, M., Vachiery, J-L., Gibbs, S., Lang, I., Torbicki, A., et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J, 37, 2015, ehv317.
10. [10] Thomas, D.W., Hinchliffe, R.F., Briggs, C., Macdougall, I.C., Littlewood, T., Cavill, I., Guideline for the laboratory diagnosis of functional iron deficiency. Br J Haematol 161 (2013), 639–648.
11. [11] Nickol, A.H., Frise, M.C., Cheng, H-Y., McGahey, A., McFadyen, B.M., Harris-Wright, T., et al. A cross-sectional study of the prevalence and associations of iron deficiency in a cohort of patients with chronic obstructive pulmonary disease. BMJ Open, 5, 2015, e007911.
12. [12] Effect of Intravenous Iron (Ferinject®) on Exercise Capacity and Quality of Life of Stable COPD Patients.[clinicaltrials.gov/show/ NCT02416778].
13. [13] Jankowska, E.A., von Haehling, S., Anker, S.D., Macdougall, I.C., Ponikowski, P., Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives. Eur Heart J 34 (2013), 816–829.
14. [14] Ruiter, G., Manders, E., Happé, C.M., Schalij, I., Groepenhoff, H., Howard, L.S., et al. Intravenous iron therapy in patients with idiopathic pulmonary arterial hypertension and iron deficiency. Pulm Circ 5 (2015), 466–472.
15. [15] Vasquez, A., Logomarsino, J.V., Anemia in Chronic Obstructive Pulmonary Disease and the Potential Role of Iron Deficiency. COPD 13 (2016), 100–109.